WPRIM Management System> DCMS> Korean Journal of Urology> 2009> 50> 4

Volume: 50 Issue: 4

1. Castleman Disease Misdiagnosed as a Neoplasm of the Kidney. Page:413—416
2. Basal Cell Carcinoma of the Prostate. Page:408—412
3. Prostatic Ductal Adenocarcinoma. Page:404—407
4. A Functioning Adrenocortical Oncocytoma. Page:401—403
5. Effects of Intravesical Instillation of Antimuscarinics on Bladder Overactivity Induced by Intravesical Instillation of Adenosine Triphosphate in Rats. Page:396—400
6. Functional, Morphologic, and Molecular Biological Changes in the Bladder of OLETF Diabetic Rats according to Duration of Diabetes Mellitus. Page:387—395
7. Analysis of the Learning Curve for Laparoscopic Renal Surgeries in Children. Page:380—386
8. A New Method of Vasovasostomy with the Prolene Stent. Page:375—379
9. Improvement of Lower Urinary Tract Symptoms and Sexual Function after Treatment with Alpha-Blocker. Page:369—374
10. Development of a Korean Version of the Urinary Tract Infection Symptoms Assessment Questionnaire. Page:361—368
11. Efficacy of Ureteroscopic Removal of Stones with an Ureteral Access Sheath for the Treatment of Ureteral Calculi. Page:355—360
12. The Outcome of Laparoscopic Retroperitoneal Ureterolithotomy for the Management of Upper Ureteral Stones Larger than 10 mm: A Comparison with Rigid Ureteroscopic Removal of Stones with Lithoclast(R). Page:349—354
13. Change in Patients' Perspectives after Education on the Management of Benign Prostatic Hyperplasia. Page:340—348
14. Efficacy and Safety of Alfuzosin 10 mg Once Daily in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A 6-Months Study in Real Life Practice. Page:333—339
15. A Multicenter Prospective Study of the Risk Factors Affecting Bone Mineral Density in Korean Patients with Prostate Cancer. Page:327—332
16. Analysis of the Clinicopathologic Characteristics of Men with Prostate Cancer Undergoing Radical Prostatectomy in the Prostate-Specific Antigen Range of Less than 4 ng/ml. Page:320—326
17. Can We Use Single Nucleotide Polymorphism and Runt Domain Transcription Factor 3 Methylation as Tumor Markers for Bladder Cancer?. Page:311—319